by Jordana Choucair | Mar 23, 2022 | Life Sciences
Moderna Inc. said it will ask regulators to authorize its COVID-19 vaccine for children between 6 months and 6 years old. The drugmaker said that two clinical trials showed the shot generated a similar immune response as among young adults, though it was less...
by Jordana Choucair | Mar 23, 2022 | Life Sciences
AstraZeneca announced it has invested roughly $33 million in Huma, a U.K.-based medical technology start-up, as part of a broader commercial partnership between the two firms. The move will enable Huma, which develops remote patient monitoring systems, to expand...
by Jordana Choucair | Mar 23, 2022 | Providers
The Occupational Safety and Health Administration (OSHA) will hold a public hearing April 29 about its emergency temporary standard to protect health care workers from workplace exposure to COVID-19. The temporary standard required health care providers to provide...
by Jordana Choucair | Mar 23, 2022 | Providers
Johnson & Johnson (J&J) notified its customers that effective May 2 it will no longer offer 340B-discounted products to contract pharmacies. J&J said the decision is based on a desire to cut off any duplicative discounts or diversion, noting that “the...
by Jordana Choucair | Mar 22, 2022 | D.C. News
The White House again urged Congress to allocate $22.5 billion in supplemental COVID-19 aid without offsets. According to the administration, it has about $300 billion in unspent COVID-19 funding, of which $240 billion is fully and publicly allocated, including $105...
Recent Comments